• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates
Home » Argentum sues IP firm, lawyer over lapsed patent | Legal News

Argentum sues IP firm, lawyer over lapsed patent | Legal News

December 16, 2011 By MassDevice staff

Argentum Medical, Noble Biomaterials

Argentum Medical is suing its former intellectual property law firm after it lost a patent infringement suit it filed against Noble Biomaterials.

Geneva, Ill.-based Argentum filed the suit against Noble in late 2007, alleging that Noble’s SilverSeal anti-microbial bandages infringed one of its patents, but the U.S. District Court for Middle Pennsylvania dismissed the case on the grounds that Argentum did not have exclusive rights to the patent. That prompted a counter-claim by Noble that Argentum and its management, namely chairman and CEO Gregg Silver and president Tom Miller, “pursued baseless litigation and falsely advised the market” that Noble infringed the patent.

The jury decided in Scranton, Pa.-based Noble’s favor, awarding $1 million in compensatory damages, $1 million from Miller and $1.25 million from Silver, respectively, in punitive damages. The court later added a $1 million judgment against Argentum for filing the patent suit in bad faith. Argentum later lost a bid for a new trial.

Sign up to get our free newsletters delivered straight to your inbox

Now Argentum wants a jury to decide whether its former patent attorney, Joseph Fuchs, and his Chicago law firm, Rockey Depke & Lyons, were negligent in their prosecution of the case against Noble. Saying it paid $675,000 to Rockey (and another $900,000 to the firm it hired after it fired Rockey in July 2010), Argentum is seeking judgments of $5 million in compensatory damages against Fuchs and the law firm, as well as legal costs and pre- and post-judgment interest.

Argentum has appealed the case against Noble to the U.S. Court of Appeals for the Federal Circuit, according to court documents.

CardioNet nears settlement of shareholder suit

CardioNet (NSDQ:BEAT) said it’s nearing a settlement in a shareholders’ lawsuit accusing the mobile cardiac monitoring firm of misleading investors about Medicare reimbursement.

The deal with the West Palm Beach Police Pension Fund would see Conshohocken, Pa.-based CardioNet pay nearly $7.3 million to settle the case, according to a press release.

The pension fund sued CardioNet in March 2010, alleging that CardioNet, then-president and CEO Randy Thurman and CFO Martin Galvan issued too-aggressive earnings forecasts that sent the company’s stock soaring to artificially high levels. Shares reached $19.60 May 19, according to court documents, after the company released its guidance for 2009 through 2011. But on June 30, CardioNet lowered its 2009 guidance and rescinded its forecast for 2010 and 2011 “based on lower-than-anticipated commercial reimbursement rates,” according to the documents.

That sent shares plunging more than 41 percent to $9.57 July 1, down from $16.32 on June 30.

Then came news that Pennsylvania’s Medicare carrier, Highmark Medicare Services, was slashing its reimbursement rate for Mobile Cardiac Outpatient Telemetry by 33 percent.

That prompted CardioNet to rescind its 2009 guidance and sent share prices down another 34 percent, from $8.83 to a $5.87 close July 13.

CardioNet beat another, similar lawsuit in August 2010. Read more

Courts uphold preemption doctrine in suits against Medtronic, Thoratec
Federal courts in Pennsylvania and Louisiana ruled for Medtronic (NYSE:MDT) and Thoratec (NSDQ:THOR) on preemption grounds in a pair of unrelated product liability lawsuits.

The preemption doctrine, enshrined into law in the U.S. Supreme Court’s 2008 decision in Riegel v. Medtronic, holds that patients can’t sue medical device makers in state courts over products that went through the FDA’s most stringent review process, called pre-market approval.

The U.S. District Court for Eastern Pennsylvania shot down a lawsuit filed over a recalled Medtronic insulin pump, ruling that the plaintiff failed to prove that Pennsylvania law trumps preemption.

And the U.S. District Court for Eastern Louisiana ruled for Thoratec along similar grounds in a case involving the failure of one of its implantable heart pumps, whose failure allegedly led to the cardiac arrest and death of a patient. Read more

Spinal Kinetics claims win in patent case filed by Synthes
A jury in the U.S. District Court for Northern California ruled that Spinal Kinetics’ M6 artificial disk replacement does not infringe a patent owned by Johnson & Johnson’s (NYSE:JNJ) soon-to-be subsidiary, Synthes Inc.

The jury found the patent to be invalid, according to a press release. Read more

EndoChoice sues trio over Cinchpad patent
EndoChoice Inc. sued a trio of firms, Austin Medical, AVID Medical and Cygnus Medical, in the U.S. District Court for Northern Georgia, alleging that each infringes the patent covering its Cinchpad scope transport pad.

Alpharetta, Ga.-based EndoChoice, which inked a GPO supply deal with Premier this week, is no stranger to the courtroom. The company is a defendant in lawsuit filed by Boston Scientific (NYSE:BSX) in the U.S. District Court for Massachusetts, accusing Cook Group of violating the quartet of patents with its Evolution stenting system. Read more

Filed Under: Legal News, News Well, Patent Infringement Tagged With: Argentum Medical, Austin Medical, AVID Medical, CardioNet Inc., Cygnus Medical, depuysynthes, EndoChoice, Legal Roundup, Noble Biomaterials, Spinal Kinetics, Thoratec Corp.

In case you missed it

  • Lyra Therapeutics appoints new chief medical officer
  • Masimo’s SafetyNet monitoring reduced length of COVID-19 hospital stays, study says
  • CeQur is launching a discreet, convenient ‘wearable insulin pen’
  • Teva appoints former Vertex exec as new head of R&D, CMO
  • Enovis partners with Kelvi on hot and cold therapies
  • West Pharmaceutical Services debuts new needle syringe system
  • Titan Medical names Cary G. Vance as new president, CEO
  • Acutus completes first closing in left-heart access portfolio sale to Medtronic
  • FDA clears Intuitive, Siemens Healthineers imaging integration for robotic bronchoscopy
  • FDA backs COVID-19 boosters with BA.4/5 spike proteins for fall
  • How safe is health information after the overturning of Roe?
  • Smith+Nephew opens new plant in Malaysia
  • BD launches combination COVID-19, flu, RSV diagnostic test
  • Zimmer Biomet creates independent nonprofit organization to reduce health disparities
  • Dexcom focuses on early diabetes diagnosis as COVID links emerge
  • Nasdaq grants Titan Medical 180-day extension to regain compliance
  • Aerin Medical reports positive 4-year results for VivAer treatment

RSS From Medical Design & Outsourcing

  • Supply Chain EVP Greg Smith sees fewer suppliers in Medtronic’s future
    All eyes are on Medtronic’s global operations and supply chain leader as he works to modernize its operations and scrutinize suppliers. EVP of Global Operations and Supply Chain Greg Smith anticipates fewer suppliers in Medtronic’s future, he said in an interview this week. Smith spoke with DeviceTalks Editorial Director Tom Salemi in his first published… […]
  • CeQur is launching a discreet, convenient ‘wearable insulin pen’
    CeQur designed its Simplicity device to make insulin delivery as seamless as possible for people with diabetes. When it comes to managing diabetes, CeQur wants to make insulin therapy as convenient as possible. For those who prefer to manage their own insulin delivery, the Simplicity device might just do exactly that. Simplicity, a wearable, disposable… […]
  • Meddux opens new facility in Colorado
    Engineering, design, development and manufacturing company Meddux announced that it opened a new facility in Boulder, Colorado. The new, 22,000-square-foot facility doubles the overall square footage from its previous location in Colorado. According to a news release, it helps the company to quadruple its product development area and double its manufacturing footprint. Meddux’s new facility… […]
  • Reducing the Overall Cost of Validation
    By PTI Engineered Plastics Reliable medical devices and equipment are essential for researchers and doctors to accurately diagnose and treat a wide range of diseases. That is why there is such stringent oversight from the FDA to ensure these products meet the necessary requirements and specifications. To ensure compliance with regulators, manufacturers follow installation qualification… […]
  • BBS Automation has a deal to buy medtech supplier Kahle Automation
    BBS Automation said it plans to purchase high-speed automation supplier Kahle Automation to expand its medtech and life sciences business. Kahle will operate as Kahle – a BBS Company, according to a news release from Munich, Germany-based BBS and Lombardy, Italy-based Kahle. The deal is subject to regulatory approval. Terms were not disclosed. Kahle’s co-owners —… […]
  • How safe is health information after the overturning of Roe?
    The U.S. Department of Health and Human Services today issued guidance meant to better protect women’s health information as state abortion bans kick in after the U.S. Supreme Court’s overturning of Roe v. Wade. Despite the HHS actions, women may still wonder whether their health information is entirely safe going forward — a potential challenge… […]
  • Dexcom focuses on early diabetes diagnosis as COVID links emerge
    New evidence is showing that COVID-19 may increase a person’s risk of diabetes, but it could be years until we know for sure. In the meantime, Dexcom (Nasdaq:DXCM) is getting ready, VP of Global Clinical Initiatives Tomas Walker said. Walker recently spoke with Medical Design & Outsourcing to discuss the San Diego-based diabetes device developer’s… […]
  • Blackrock Neurotech and Pitt work on first at-home BCI system for remote trials
    Blackrock Neurotech and the University of Pittsburgh’s Rehab Neural Engineering Labs (Pitt RNEL) are working together on the first portable brain-computer interface (BCI) to allow patients to participate in research trials from home. A Blackrock representative said it’s the final step as the company prepares to launch its first commercial product early next year. Salt… […]
  • How medical device companies are responding to abortion bans
    Days after the U.S. Supreme Court’s decision to overturn Roe v. Wade’s protection of abortion rights, medical device companies are among those reassuring workers about healthcare access. Corporate communications to employees and the public at large come as trigger laws in nearly half of the states outlaw abortion immediately. Some medtech companies are not using… […]
  • Philips updates on testing results for recalled ventilators
    Royal Philips (NYSE:PHG) says only a small portion of returned respiratory devices displayed the sound abatement foam degradation that sparked a massive recall. Repeated ozone cleaning may have made the problem worse. Those were some of the major takeaways from an update Philips provided today on a comprehensive test and research program it implemented after its… […]
  • ResMed names Lucile Blaise as new Sleep & Respiratory Care leader
    Lucile Blaise will be the new president of ResMed’s Sleep & Respiratory Care business starting July 1, ResMed (NYSE: RMD) said today. She replaces Jim Hollingshead, who became president and CEO of Insulet (Nasdaq:PODD) on June 1. ResMed President and COO Rob Douglas is serving as interim president of the Sleep & Respiratory Care during… […]

Leave a Reply

You must be logged in to post a comment.

Primary Sidebar

DeviceTalks Weekly

July 1, 2022
Boston Scientific CEO Mike Mahoney on building a corporate culture that drives high growth results
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World

Device Talks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS